Financial Services » Investing & Securities | BioTech Capital Ltd.

BioTech Capital Ltd. | Income Statement

Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
15.60
11.40
71.20
28.50
62.90
Unusual Expense
1,738.00
300.00
700.00
-
1,001.80
Pretax Income
1,889.00
507.00
870.80
516.50
1,467.80
Consolidated Net Income
1,889.00
507.00
870.80
516.50
1,467.80
Net Income
1,889.00
507.00
870.80
516.50
1,467.80
Net Income After Extraordinaries
1,889.00
507.00
870.80
516.50
1,467.80
Net Income Available to Common
1,889.00
507.00
870.80
516.50
1,467.80
EPS (Basic)
0.03
0.01
0.01
0.00
0.01
Basic Shares Outstanding
74,554.10
84,664.90
98,761.10
114,567.60
128,977.30
EPS (Diluted)
0.03
0.01
0.01
0.00
0.01
Diluted Shares Outstanding
74,554.10
84,664.90
98,761.10
114,567.60
128,977.30
Total Expense
166.60
218.40
242.00
545.00
529.00
Operating Income
151.00
207.00
170.80
516.50
466.00

About BioTech Capital

View Profile
Address
697 Burke Road
Camberwell Victoria (VIC) 3124
Australia
Employees -
Website http://www.btchealth.com.au
Updated 09/14/2018
BTC Health Ltd operates as an investment fund, which engages in the provision of professional solutions to high-growth biotech, medtech, and pharmaceutical companies. It offers its products under the Carisolv and Perisolv brands. The company was founded on March 14, 2000 and is headquartered in Camberwell, Australia.

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.